US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn
Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)
Rebecca Stevenson
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

More Markets

NZ stocks end flat amid Fletcher-SkyCity legal woes
Markets Market Close

NZ stocks end flat amid Fletcher-SkyCity legal woes

Tesla's 14% drop again highlighted the general state of global market uncertainty.

Jamie Gray 06 Jun 2025
SkyCity claims it is entitled to $330m in damages from Fletcher Building
Markets

SkyCity claims it is entitled to $330m in damages from Fletcher Building

The original delivery date of the International Convention Centre was January 2019. 

Rebecca Howard 06 Jun 2025
10 NZ firms could get slice of $200m Fisher KiwiSaver cash
Markets

10 NZ firms could get slice of $200m Fisher KiwiSaver cash

Private equity investing will benefit both KiwiSavers and business, fund manager says.